Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biodesix, Inc. - Common Stock
(NQ:
BDSX
)
21.47
-0.31 (-1.42%)
Delayed Quote
Updated: 11:47 AM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
October 22, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification
October 19, 2026
New CHEST framework developed by a renowned multidisciplinary panel with expertise in building and managing lung nodule programs across diverse clinical practices
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
October 19, 2026
Partnership with Vanderbilt University and Vanderbilt Health accelerates development of the first radiomics-based test for lung nodule risk assessment
From
Biodesix, Inc.
Via
GlobeNewswire
BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak
↗
September 02, 2026
Via
Chartmill
Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip
↗
August 05, 2026
Via
Chartmill
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance
↗
May 04, 2026
Via
Chartmill
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability
↗
February 26, 2026
Via
Chartmill
Topics
Earnings
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
October 13, 2026
New sponsored and independent research evaluates clinical utility, patient follow-up, and diagnostic test sequencing
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
September 24, 2026
Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
September 14, 2026
Industry-leading QA/RA excellence accelerates patient access to Biodesix Lab testing, which helps improve overall outcomes for patients with lung nodules
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Upcoming Investor Conferences
September 03, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix (BDSX) Q2 2026 Earnings Call Transcript
↗
August 12, 2026
Revenue jumped 34% as diagnostic testing surged on primary care adoption gains.
Via
The Motley Fool
Topics
Earnings
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference
↗
August 12, 2026
Biodesix (NASDAQ:BDSX) said its commercial expansion, broader primary care outreach and recently published clinical data supporting use of its Nodify CDT test in smaller lung nodules are among the...
Via
MarketBeat
Biodesix Q2 Earnings Call Highlights
↗
August 05, 2026
Biodesix (NASDAQ:BDSX) reported second-quarter 2026 revenue growth of 34% year over year, supported by increased diagnostic test volumes, higher average revenue per test and continued expansion of its...
Via
MarketBeat
Topics
Earnings
Biodesix Announces Second Quarter 2026 Results and Highlights
August 05, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 04, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Upcoming Investor Conferences
May 21, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix (BDSX) Q1 2026 Earnings Transcript
↗
May 04, 2026
Biodesix (BDSX) Q1 2026 Earnings Transcript
Via
The Motley Fool
Biodesix BDSX Q2 2025 Earnings Call Transcript
↗
May 04, 2026
Biodesix BDSX Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Biodesix Announces First Quarter 2026 Results and Highlights
May 04, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
April 20, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 09, 2026
Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Culture
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
April 06, 2026
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
March 20, 2026
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix (BDSX) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Biodesix (BDSX) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
February 26, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Upcoming Investor Conferences
February 24, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
From
Biodesix, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
